February 18, 2019

EHL FIX review

An up to date review of evidence for the efficacy and safety of nonacog beta pegol, an extended half-life FIX for haemophilia B, covers outcomes from the PARADIGM trial programme (Drug Des Devel Ther 2018;12:2933-2943). The review is free to access at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141116/pdf/dddt-12-2933.pdf